FDA Considers Tanezumab Application for Chronic OA Pain
No Gain with Pain: Exercise & Physical Function in Patients with Rheumatic Disease
Mindfulness-Based Therapy Improves Function in Fibromyalgia
Opioids Commonly Prescribed for Gout Attacks
Tanezumab’s Phase 3 Results for OA
IV Meloxicam Stalls at FDA; Plus Health Canada Approves Risankizumab for Plaque Psoriasis
Ibuprofen an Option for Early Pain Control after Hip Replacement
Arthralgias in Children: What to Do When Kids Present with Joint Pain
Emerging Treatments for OA: New Therapies Target Joint Pain, Not Just Structural Damage
- 1
- 2
- 3
- …
- 25
- Next Page »